CA Stock MarketDetailed Quotes
CSCI Cosciens Biopharma Inc
- 5.200
- +0.100+1.96%
15min DelayMarket Closed Oct 15 16:00 ET
16.20MMarket Cap-1414P/E (TTM)
5.200High5.200Low278Volume5.200Open5.100Pre Close1.44KTurnover9.00052wk High0.01%Turnover Ratio3.12MShares4.64052wk Low-3.675EPS TTM14.80MFloat Cap9.000Historical HighLossP/E (Static)2.85MShs Float4.640Historical Low-2.541EPS LYR0.00%Amplitude--Dividend TTM0.46P/B1Lot Size--Div YieldTTM
Cosciens Biopharma Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 225.89%27.8M | -62.18%3.51M | -34.49%6.67M | -34.49%6.67M | -11.50%8.35M | -3.30%8.53M | 32.05%9.29M | 66.75%10.18M | 66.75%10.18M | 62.49%9.44M |
| -Cash and cash equivalents | 225.89%27.8M | -62.18%3.51M | -34.49%6.67M | -34.49%6.67M | -11.50%8.35M | -3.30%8.53M | 32.05%9.29M | 66.75%10.18M | 66.75%10.18M | 62.49%9.44M |
| -Accounts receivable | 4.94%1.24M | -42.30%1.24M | -93.93%126.11K | -93.93%126.11K | -66.03%723.09K | -54.77%1.18M | -24.11%2.15M | 26.60%2.08M | 26.60%2.08M | -0.05%2.13M |
| Total current assets | 141.33%33.21M | -40.35%8.8M | -26.22%11.19M | -26.22%11.19M | -2.15%13.25M | 3.65%13.76M | 27.58%14.76M | 55.90%15.17M | 55.90%15.17M | 45.94%13.54M |
| Non current assets | ||||||||||
| -Accumulated depreciation | -7.17%-10.19M | -11.23%-9.97M | -14.16%-9.79M | -14.16%-9.79M | -18.23%-9.63M | -14.88%-9.51M | -9.76%-8.96M | -12.34%-8.57M | -12.34%-8.57M | -12.22%-8.15M |
| -Long term equity investment | -17.37%1.28M | -18.57%1.3M | -15.72%1.4M | -15.72%1.4M | -7.28%1.44M | -9.36%1.55M | -13.06%1.59M | -10.45%1.66M | -10.45%1.66M | -18.74%1.55M |
| Non current note receivables | --952K | --484.64K | --74.46K | --74.46K | ---- | ---- | ---- | --0 | --0 | --0 |
| -Goodwill | 39,694.48%3.34M | -24.93%6.57K | -21.77%7.26K | -21.77%7.26K | -21.76%7.63K | -23.25%8.38K | -26.17%8.76K | -23.95%9.27K | -23.95%9.27K | -23.69%9.75K |
| Regulatory assets | 9.46%1.36M | -36.45%1.39M | -86.38%289.51K | -86.38%289.51K | -64.18%783.3K | -53.78%1.24M | -24.31%2.19M | 26.73%2.13M | 26.73%2.13M | 1.22%2.19M |
| Non current deferred assets | 11.46%719K | 15.24%728.39K | 17.78%741.9K | 17.78%741.9K | 12.19%628.92K | 8.43%645.1K | 2.93%632.04K | 4.76%629.9K | 4.76%629.9K | 17.66%560.57K |
| Total assets | --117K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | 39.62%407K | 5.31%296.99K | 9.42%298.68K | 9.42%298.68K | 25.64%287.83K | 23.82%291.51K | 19.94%282.02K | 19.99%272.96K | 19.99%272.96K | -20.47%229.08K |
| -Current capital lease obligation | 39.62%407K | 5.31%296.99K | 9.42%298.68K | 9.42%298.68K | 25.64%287.83K | 23.82%291.51K | 19.94%282.02K | 19.99%272.96K | 19.99%272.96K | 1.95%229.08K |
| -accounts payable | --3.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Total tax payable | 576.27%13.92M | -44.24%1.3M | -43.34%1.4M | -43.34%1.4M | -23.42%1.72M | -8.39%2.06M | 17.76%2.32M | 33.20%2.46M | 33.20%2.46M | -13.17%2.25M |
| -Other payable | --332K | --7.4K | --7.54K | --7.54K | ---- | ---- | ---- | ---- | ---- | ---- |
| Current accrued expenses | --1.78M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current provisions | --432K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current deferred liabilities | --314K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current liabilities | 1,518.18%9.9M | 14.47%1.24M | -15.34%1.31M | -15.34%1.31M | 95.65%1.2M | -14.06%611.68K | 59.04%1.08M | 103.02%1.55M | 103.02%1.55M | -46.39%615.71K |
| Non current liabilities | ||||||||||
| -Long term debt | -17.37%1.28M | -18.57%1.3M | -15.72%1.4M | -15.72%1.4M | -7.28%1.44M | -9.36%1.55M | -13.06%1.59M | -10.45%1.66M | -10.45%1.66M | -18.74%1.55M |
| Non current accrued expenses | -0.43%11.5M | 0.37%11.68M | -2.62%11.63M | -2.62%11.63M | -8.08%11.03M | -11.44%11.55M | -15.62%11.64M | -13.02%11.94M | -13.02%11.94M | -13.89%12M |
| Employee benefits | --11.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Preferred securities outside stock equity | --472K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | 792.05%23.82M | -25.57%2.54M | -32.54%2.71M | -32.54%2.71M | 2.15%2.93M | -9.75%2.67M | 28.35%3.41M | 53.58%4.01M | 53.58%4.01M | -23.37%2.87M |
| Shareholders'equity | ||||||||||
| Share capital | 74.62%22M | 0.25%12.38M | 2.47%12.61M | 2.47%12.61M | 0.83%12.3M | -2.53%12.6M | -6.92%12.34M | -5.28%12.3M | -5.28%12.3M | -6.01%12.2M |
| -common stock | 74.62%22M | 0.25%12.38M | 2.47%12.61M | 2.47%12.61M | 0.83%12.3M | -2.53%12.6M | -6.92%12.34M | -5.28%12.3M | -5.28%12.3M | -6.01%12.2M |
| Additional paid-in capital | 5.62%3.91M | 2.89%3.69M | 7.70%3.74M | 7.70%3.74M | 5.75%3.64M | 1.90%3.7M | -4.71%3.58M | -5.38%3.47M | -5.38%3.47M | -6.24%3.44M |
| Gains losses not affecting retained earnings | ---1.22M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other equity interest | --309K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total equity | 92.33%50.05M | -19.67%21.77M | -14.74%23.7M | -14.74%23.7M | -4.57%24.97M | -3.57%26.02M | 4.01%27.09M | 14.17%27.8M | 14.17%27.8M | 7.02%26.17M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data